Dr. James Gulley to Present Cancer Conference Keynote Address

James L. Gulley, MD, PhD, Clinical Director and Co-Director for the Center for Immuno-Oncology and the National Cancer Institute (NCI), Bethesda, MD, will present the keynote address at the 2024 ACS Cancer Conference. 

Dr. Gulley is an internationally recognized expert in cancer immunotherapy with a strong interest in prostate cancer. His areas of expertise include cancer immunology and immunotherapy, prostate cancer, therapeutic cancer vaccines, immune checkpoint inhibitors, clinical trials, and the combination of immunotherapy with other therapy.

Since 1998, he has overseen a variety of clinical trials at the NCI. These innovative, investigator-initiated studies involve the use of cancer immunotherapy to initiate and expand immune responses and to allow immune responses to be effective within the tumor microenvironment.

Register today to attend the ACS Cancer Conference at the Hilton Hotel in Austin, Texas,  February 22–24.